Clinical Trials Directory

Trials / Completed

CompletedNCT07456514

Feasibility and Acceptability of a Co-produced Intervention to Improve Physical Activity and Motor Competence Amongst Children With Intellectual Disabilities and/or Autism Spectrum Disorder: Movement Matters

Movement Matters: Feasibility of a Pilot Intervention to Improve Physical Activity and Motor Competence Amongst Children With Intellectual Disabilities

Status
Completed
Phase
Study type
Observational
Enrollment
43 (actual)
Sponsor
Liverpool John Moores University · Academic / Other
Sex
All
Age
7 Years – 11 Years
Healthy volunteers
Accepted

Summary

The goal of this observational study is to find out whether an intervention designed to improve physical activity levels and movement skills is practical and acceptable for children aged 7-11 years with intellectual disabilities and/or autism spectrum disorder. The intervention will be designed with input from people with lived experience, including professionals working in schools, physical education, sport, health services, and charities, as well as parents and families. The study will explore whether this type of intervention can be realistically delivered in special educational needs schools as part of their usual day-to-day activities. The main question the study aims to answer is: • Is an intervention to improve physical activity and motor skills feasible and acceptable for special educational needs schools? Participating schools will implement the intervention for six weeks. Several outcomes related to feasibility and acceptability will be measured to understand how well the intervention works in a school setting.

Conditions

Interventions

TypeNameDescription
OTHERMovement MattersA multi-component intervention comprising of Teacher/Coach Training, School-Based Physical Activity, Family Co-Participation in PA, Parent Education, School Multi-Skill Event, Use of Role Models.

Timeline

Start date
2022-03-16
Primary completion
2023-07-14
Completion
2023-07-14
First posted
2026-03-06
Last updated
2026-03-06

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT07456514. Inclusion in this directory is not an endorsement.